LANXESS disinfectant kills coronavirusSARS-CoV-2 in just 60 seconds

  • Efficacy of Rely+On Virkon scientifically proven
  • Proven to protect against the COVID-19 virus

Mumbai : Rely+On Virkon broad spectrum disinfectant, produced by specialty Chemicals Company LANXESS, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus.

This is the finding of a recent study LANXESS commissioned through independent analysis laboratory Microbac Laboratories, Inc. in accordance with the U.S. Environmental Protection Agency (EPA) compliant test methods, for products intended for virucidal hard surface disinfection.

Rely+On Virkon achieved rapid and complete inactivation of the SARS-CoV-2 virus at a dilution ratio of 1:100 in just 60 seconds, and at an economical 1:600 in-use dilution with a 10 minute contact time.

Corresponding efficacy data has to be provided for disinfectants that claim to combat SARS-CoV-2. Microbac is one of the few testing laboratories worldwide that U.S. health authority CDC (Center for Disease Control) has certified to undertake such tests.

Good hygienic cleaning and disinfection practices more important than ever

“Neither a vaccine nor generally approved medications are currently available to us in the fight against the global coronavirus pandemic.

So alongside social distancing and hand-washing, disinfection remains a highly important means to help prevent the spread of this life-threatening respiratory illness,” says Anneliese Bischof, Business Director Disinfection at LANXESS. “Right now, good hygiene cleaning and disinfection practices are more important than ever. The fact that Rely+On Virkon inactivates SARS-CoV-2 so quickly will help reassure people that the disinfectant product they are using is both fast and effective in practical use,” underlines Bischof.

Rely+On Virkon is a powder disinfectant concentrate diluted in water for application as a spray on hard surfaces and equipment (non-medical). It can therefore help to reduce the risk of cross-contamination from surfaces, door handles, tables or chairs during disinfection measures at public transport terminals, airports, hospitals, clinics, shopping malls, etc.

The LANXESS Material Protection Products business unit produces a wide range of scientifically based disinfection technologies under the Rely+On and Virkon brand. Detailed information is available at http://www.virkon.com and https://coronavirus.lanxess.com/.

  • Related Posts

    The Revolutionary AI Health Monitoring Tool Every Indian Should Know About

    New Delhi [India], September 17: In a significant leap forward for healthcare technology, a groundbreaking development in healthcare has emerged from India. Quick Vitals, an AI-powered health monitoring app, is…

    B2B Supply Chain FinTech, QuiD Cash unveils state of the art tech suite connecting anchors, MSMEs and lenders

    The startup plans to apply for patent on its predictive credit modelling engine – QuiD Score New Delhi [India] September 16: Bangalore based Fintech startup QuiD Cash, announced the launch of its proprietary state…

    You Missed

    The Revolutionary AI Health Monitoring Tool Every Indian Should Know About

    The Revolutionary AI Health Monitoring Tool Every Indian Should Know About

    Healing Hospital Chandigarh Achieves Groundbreaking Success in Sleep Apnea Surgery for High BMI Patient

    Healing Hospital Chandigarh Achieves Groundbreaking Success in Sleep Apnea Surgery for High BMI Patient

    The Hidden Dangers of Modern Lifestyle Habits: A Growing Cancer Concern

    The Hidden Dangers of Modern Lifestyle Habits: A Growing Cancer Concern

    Sunpure Research Incubation Centre secures patent for “CURCUBOOST”

    Sunpure Research Incubation Centre secures patent for “CURCUBOOST”

    India’s First Mental Health Education Program: Empowering Teachers and Upskilling for the 21st Century

    India’s First Mental Health Education Program: Empowering Teachers and Upskilling for the 21st Century

    IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India

    IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India